Inge Vrelust

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo Van Tendeloo, Ann Van de Velde, Ann Van Driessche et al. · Proceedings of the National Academy of Sciences · 2010 · 372 citations · Full text

Medicine, Immunology, Oncology +17

Familial hypertryptasemia with associated mast cell activation syndrome

Vito Sabato, Els Van de Vijver, Margo M. Hagendorens et al. · Journal of Allergy and Clinical Immunology · 2014 · 51 citations · Full text

Life Sciences, Genetics, Molecular Genetics +7

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry

Timothy Devos, Violaine Havelange, Koen Theunissen et al. · Annals of Hematology · 2021 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15

Targeted next‐generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics

Brigitte Maes, J. Willemse, An Broekmans et al. · International Journal of Laboratory Hematology · 2017 · 15 citations

Medicine, Genetics, Oncology +17

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Lorenzo Falchi, Marcel Nijland, Huiqiang Huang et al. · The Lancet · 2025 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +15